SOX3 and ovarian carcinoma: Intriguingly, studies examining the response to chemotherapy drugs like cisplatin found that SOX3 expression was lower in tissues that were more resistant to the drug, suggesting a complex involvement of SOX3 in the progression of ovarian cancer [52] (Table 1).